FormWeb • dabigatran

Pharmacists will evaluate indication and current patient status and will optimize dosing and monitor labs “per policy”
Pharmacists will document in Epic using i-Vents at least daily and using consult notes at least once weekly on Thursdays
Pharmacists must provide patient education for all patients on therapy

Additional information

Therapeutic anticoagulant transition guide 2019

Last updated: Sep. 9, 2021

Black Box Warnings: Discontinuation without anticoagulation
Do Not Crush/Manipulate: Capsule - Note: bioavailability increases by 75% when the pellets are taken without the capsule shell

This site is intended for the staff of Houston Methodist.
While others may view accessible pages, Houston Methodist makes no warranty, express or implied,
as to the use of this information outside of Houston Methodist.